Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.54
-0.14 (-1.40%)
Mar 17, 2026, 12:34 PM EDT - Market open
Vir Biotechnology Employees
Vir Biotechnology had 367 employees as of December 31, 2025. The number of employees decreased by 41 or -10.05% compared to the previous year.
Employees
367
Change (1Y)
-41
Growth (1Y)
-10.05%
Revenue / Employee
$186,801
Profits / Employee
-$1,193,425
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 367 | -41 | -10.05% |
| Dec 31, 2024 | 408 | -179 | -30.49% |
| Dec 31, 2023 | 587 | 11 | 1.91% |
| Dec 31, 2022 | 576 | 132 | 29.73% |
| Dec 31, 2021 | 444 | 117 | 35.78% |
| Sep 30, 2021 | 395 | 98 | 33.00% |
| Jun 30, 2021 | 367 | 114 | 45.06% |
| Mar 31, 2021 | 340 | 103 | 43.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 645 |
| Ardelyx | 489 |
| Capricor Therapeutics | 160 |
| Precigen | 143 |
| Zenas BioPharma | 130 |
| Olema Pharmaceuticals | 122 |
| CytomX Therapeutics | 121 |
| AtaiBeckley | 99 |
VIR News
- 18 days ago - Vir Biotechnology to Participate in Upcoming Investor Conferences - Business Wire
- 19 days ago - Vir Biotechnology Announces Pricing of Public Offering of Common Stock - Business Wire
- 20 days ago - Vir Biotechnology Announces Proposed Public Offering of Common Stock - Business Wire
- 20 days ago - Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish - Seeking Alpha
- 20 days ago - These Analysts Boost Their Forecasts On Vir Biotechnology - Benzinga
- 21 days ago - What's Happening With VIR Stock? - Forbes
- 21 days ago - Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire